News Blog
Catalyst & St. Jude – Working to Treat and Defeat Childhood Cancer
At Catalyst, our company culture is rooted in our people-first foundational belief and a desire to do the right thing. From our philanthropy and volunteering to our sustainability initiatives, we strive to collaborate openly and inclusively for the best impact on...
PJammin’ For Kids With Cancer 2021
According to the American Cancer Society, in 2021, more than 10,000 children under the age of 15 will be diagnosed with some form of cancer. Thanks to the research and development of better therapies, the survival rate has increased to over 80% over the last few...
10 Things a Cancer Survivor Wants You To Know
Catalyst's UK-based Senior Director, Clinical Operations, Nicola Stanislaus, was a young mother who found herself diagnosed with stage II malignant melanoma. Despite disturbing odds and doctors telling her she had a 60% chance of surviving five years, Nicola is here...
Catalyst Named to Inc. 5000 List for Second Year As One of Fastest-Growing Private Companies
Global Clinical Development Organization Ranked No. 934 for 2021 Wilmington, NC, 17 August 2021 – For the second consecutive year, Wilmington-headquartered Catalyst Clinical Research is ranked among the Inc. 5000’s list of fastest-growing private companies in...
Catalyst SVP Keya Watkins Honored as Business Diversity Leader
Philadelphia Business Journal Recognizes Watkins’ Career Contributions Wilmington, NC, 20 July 2021 – Keya Watkins, senior vice president of clinical development operations at Catalyst Clinical Research, has been honored by the Philadelphia Business Journal as a 2021...
Accelerating Clinical Studies While Reducing Operational Cost
Leveraging a Flexible Resourcing Model to Achieve Study Success Fluctuating resourcing demand has been a challenge for the broader clinical research industry since the beginning of time. Only recently has the demand for flexible and innovative solutions to address...
